BSE filing, NSE: TEJNAKSH. Summary written from the filing by ALFA Finder's alert engine.
Tejnaksh Healthcare Ltd: key numbers
- Share price
- ₹12.59
- Market cap
- ₹25.57 Cr
- Revenue (annual)
- ₹10.79 Cr
- Net profit (annual)
- ₹1.23 Cr
- P/E (TTM)
- 20.7×Sector 52.0×
- Promoter holding
- 73.83%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tejnaksh Healthcare Ltd
All →Tejnaksh Healthcare Business Update
Tejnaksh Healthcare announced publication of a multicentric validation study of its Pflow device in the Indian Journal of Urology. The filing is a scientific publication update with no financial value.
Tejnaksh Healthcare Other Announcement
Tejnaksh Healthcare Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31(1)(b) of SEBI LODR.
Tejnaksh Healthcare Management Change
Tejnaksh Healthcare shareholders approved the re-appointment of Mr. Suhas Vasantrao Thorat as an Independent Director for a second five-year term at the 18th Annual General Meeting.
Tejnaksh Healthcare Annual General Meeting
The company issued a notice for its Annual General Meeting scheduled for September 29, 2026, to consider financial statements, director appointments, and related party transaction approvals.
Tejnaksh Healthcare Annual Report
Tejnaksh Healthcare Limited has submitted its Annual Report for the financial year 2025-26. The filing includes audited standalone and consolidated financial statements along with governance reports.
Tejnaksh Healthcare Annual General Meeting
Tejnaksh Healthcare Ltd will hold its 19th Annual General Meeting on September 29, 2026. The meeting will be conducted via video conferencing to transact ordinary and special business.
Other board meeting date announcements
All →RateGain Travel Technologies Board Meeting Date
RateGain Travel Technologies will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window closes from 1 October 2026 until 48 hours after results.
Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.